You have selected the view in French
Descriptor English: | Cyproterone | ||||
Descriptor Spanish: |
Ciproterona
| ||||
Descriptor Portuguese: | Ciproterona | ||||
Descriptor French: | Cyprotérone | ||||
Tree number(s): |
D04.210.500.745.432.219 D04.210.500.883.419 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D003534 | ||||
Scope note: | An anti-androgen that, in the form of its acetate (CYPROTERONE ACETATE), also has progestational properties. It is used in the treatment of hypersexuality in males, as a palliative in prostatic carcinoma, and, in combination with estrogen, for the therapy of severe acne and hirsutism in females. |
||||
Allowable Qualifiers: |
AA analogues et dérivés AD administration et posologie AE effets indésirables AG agonistes AI antagonistes et inhibiteurs AN analyse BL sang CF liquide cérébrospinal CH composition chimique CL classification CS synthèse chimique EC économie HI histoire IM immunologie IP isolement et purification ME métabolisme PD pharmacologie PK pharmacocinétique PO intoxication RE effets des radiations SD ressources et distribution ST normes TO toxicité TU usage thérapeutique UR urine |
||||
Pharm Action: |
Androgen Antagonists |
||||
Registry Number: | E61Q31EK2F | ||||
CAS Type 1 Name: | 3'H-Cyclopropa(1,2)pregna-1,4,6-triene-3,20-dione, 6-chloro-1,2-dihydro-17-hydroxy-, (1beta,2beta)- | ||||
DeCS ID: | 3553 | ||||
Unique ID: | D003534 | ||||
NLM Classification: | WJ 875 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1974/01/01 | ||||
Date of Entry: | 1999/01/01 | ||||
Revision Date: | 2016/05/28 |
-
-
PRODUITS CHIMIQUES ET PHARMACEUTIQUES
Composés polycycliques [D04]Composés polycycliques -
PRODUITS CHIMIQUES ET PHARMACEUTIQUES
Composés polycycliques [D04]Composés polycycliques
|
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey